OCS - Oculis Holding AG Stock - Stock Price, Institutional Ownership, Shareholders (ICSE)

Oculis Holding AG (IS:OCS) has 32 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,392,900 shares. Largest shareholders include Pivotal bioVenture Partners Investment Advisor LLC, Standard Life Aberdeen plc, Nan Fung Group Holdings Ltd, Tekla Healthcare Opportunities Fund, Tekla Healthcare Investors, Sr One Capital Management, Lp, Tekla World Healthcare Fund, Tekla Life Sciences Investors, Alyeska Investment Group, L.P., and UBS Group AG .

Oculis Holding AG (ICSE:OCS) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.

The share price as of September 9, 2025 is 2,060.00 / share. Previously, on September 10, 2024, the share price was 1,670.00 / share. This represents an increase of 23.35% over that period.

The Fund Sentiment Score (fka Ownership Accumulation Score) finds the stocks that are being most bought by funds. It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of institutional accumulation. The scoring model uses a combination of the total increase in disclosed owners, the changes in portfolio allocations in those owners and other metrics. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.

Update Frequency: Daily

See Ownership Explorer, which provides a list of highest-ranking companies.